Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers
about
High content screening as high quality assay for biological evaluation of photosensitizers in vitroSignificantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue.Photodynamic therapy in head and neck cancer.Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells.PEG-m-THPC-mediated photodynamic effects on normal rat tissues.Characterization by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry of the major photoproducts of temoporfin (m-THPC) and bacteriochlorin (m-THPBC).Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.MALDI-TOF mass spectrometric analysis for the characterization of the 5,10,15,20-tetrakis- (m-hydroxyphenyl)bacteriochlorin (m-THPBC) photoproducts in biological environment.Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.Photodynamic treatment as a novel approach in the therapy of arthritic joints.Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells.Characterization of a murine model for the rapid assessment of acute photodynamic response in tumour and muscle.A comparison of novel light sources for photodynamic therapy.Photodynamic suppression of Enterococcus faecalis using the photosensitizer mTHPC.Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.Reaction of the m-THPC triplet state with the antioxidant Trolox and the anesthetic Propofol: modulation of photosensitization mechanisms relevant to photodynamic therapy?Binding of temoporfin to the lipoprotein fractions of human serum.Photodynamic therapy of age-related macular degeneration: History and principles.Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster.New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC)Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers.Dynamic capillaroscopy: a minimally invasive technique for assessing photodynamic effects in vivo.Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in tissues by high performance liquid chromatography.Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma.Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in human plasma by high performance liquid chromatography.Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy.In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79).Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.Lipid nanoemulsions and liposomes improve photodynamic treatment efficacy and tolerance in CAL-33 tumor bearing nude miceFrom porphyrin benzylphosphoramidate conjugates to the catalytic hydrogenation of 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin.Future of oncologic photodynamic therapy.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.
P2860
Q28534928-30AF3006-8F1B-47F8-AC6D-DA1A0DFC035EQ30657983-105E16F0-7B7D-431C-A43A-DB7338ADBB34Q30773408-08ABA420-0A6C-4482-9C63-A85591BC9F13Q30818425-C16B4CC0-1859-4C8F-A179-861654F4EE87Q30884337-6CF6520D-2E85-4D8D-92E7-7D6838DF090DQ30975773-4A843AF8-C1F9-4EC7-B219-70770C49C50CQ30997562-9BC8C758-865F-4AE9-AB8B-B405BE8861C6Q31941568-165C9DDA-9D2B-4CA6-891E-21ADE9AB1883Q33185630-E06FA840-735D-4EC4-9746-F6B9E8E34931Q33208926-C71000AC-958E-4F55-A572-6430A9BAF03BQ33217635-9532ED01-A961-47D6-B597-59774FB94ABFQ33218362-900A2A54-FF27-4D81-ADC0-0CBEDF9F389EQ33247412-8C56DA7C-159C-4863-AA7A-FC3625A196A8Q33328238-8D02FDD6-2E23-499B-9B51-7B4CAB88C6E2Q33629833-05499231-08CC-44E2-9F3C-08CC2C4D9E3AQ33677869-E5967E02-4B89-455A-B8BE-57B2DA8FD7C3Q33677985-84C783EB-6732-4631-ADA9-67083993D748Q33849109-3FB13163-1420-4BD9-A04F-96B717F84403Q33952783-535F0D0F-61F2-4382-9E07-AD6EE1BDAE8DQ34151225-2E78ABD6-0D6C-4213-98AA-6AFB844F445FQ34347701-A31F7DD2-55C5-4E95-9A99-C33B4DC2CB16Q35932469-6982714F-BC5F-42A3-84B7-0F4A8E6A856DQ36081624-FE333644-B1CD-42E4-96F5-3FE395B7E307Q36135334-B72F5706-D313-4FC9-9461-615661A28F54Q36247361-FB51FE21-8CC4-40A6-9E04-4876E65C46D2Q36431077-4161E47D-4172-40E9-9E61-F30B5EC5949DQ36670934-E7E07BD8-99E4-4CC0-93E3-DB7B522B19A2Q36752543-8DB20F0C-08C5-4C0B-A346-3577A331117FQ36762859-514E1C2C-99C1-4632-B693-0F17DAC4EB34Q36763785-247642D8-48B6-4130-8F2B-8AA684CA04C1Q36774584-9F3E8174-A8CA-4971-90D8-68CAED173A43Q36776576-7FED7B9F-238A-4762-9F52-1145975DB7F0Q36859535-F9647CBC-C0F5-40CB-9851-68194898D4C8Q36859542-AAA4DC8E-5542-4DE4-9776-C1C5796F22A7Q36880367-CCD25662-B0B3-4855-890D-DDC352707B45Q36923896-6B459287-FA12-4B0D-AB0F-064D3AEFDBF8Q37307865-EC3452A7-B98E-4524-ABAB-BAAF7CC0BEF3Q37723489-00322AEB-7D55-44B4-92A1-4CFD5F1898DDQ37763099-757C193C-E5E1-4FBA-B6E0-836AE3F26A30Q37919156-A23A08AC-D942-4B92-AB6E-9C17D942CBEE
P2860
Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Hydroporphyrins of the meso-tetra
@nl
Hydroporphyrins of the meso-te ...... ies as tumour photosensitizers
@en
type
label
Hydroporphyrins of the meso-tetra
@nl
Hydroporphyrins of the meso-te ...... ies as tumour photosensitizers
@en
prefLabel
Hydroporphyrins of the meso-tetra
@nl
Hydroporphyrins of the meso-te ...... ies as tumour photosensitizers
@en
P2093
P2860
P356
P1433
P1476
Hydroporphyrins of the meso-te ...... ies as tumour photosensitizers
@en
P2093
Berenbaum MC
Winfield UJ
P2860
P304
P356
10.1042/BJ2610277
P407
P577
1989-07-01T00:00:00Z